Wedetermined the cerebrospinal fluid (CSF) levels of adenosine, a mediator of cerebral blood flow regulation, and neopterin, a macrophage-producing compound, in patients with neurological disorders. Compared to control subjects, the adenosine levels were significantly increased in the patients with acute-stage cerebral infarction (n=12, p<0.0001), acute meningitis (n=10, p<0.0001), or amyotrophic lateral sclerosis (ALS, n=12, p<0.05) (Mann-Whitney U-test). The neopterin levels were significantly increased in the 41 patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis (HAM/TSP,p<0.0001), acute meningitis (p<0.0001), ALS (p<0.05) (Mann-Whitney U-test), or acute-stage cerebral infarction (p<0.005, Student's t-test). In the analysis of 41 HAM/TSPpatients, the neopterin levels were significantly correlated with the cell number and glucose levels in the CSF, and were a sensitive marker of inflammation. Several of the HAM/TSP patients with increased adenosine levels were probably complicated with other diseases. The increased neopterin levels in the HAM/TSPgroup persisted, suggesting that the mononuclear cellular infiltration remained for a long time. (Internal Medicine 38: 133-139, 1989) 
Introduction
Adenosine is a mediator of the metabolic regulation of cerebral blood flow (CBF) and may be a critical factor in this regulation (1) (2) (3) . Brain adenosine levels have been shown to rise in the brain interstitial fluid or cerebrospinal fluid (CSF) soon after the onset of total ischemia and hypoxia (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) . Adenosine in CSFis thought to be responsible for the cerebral vasodilatation which increases CBF,because a ventriculocisternal perfusion of adenosine causes an increase in CBF (14) , and because the instillation of adenosine deaminase or a potent adenosine receptor blocker, 8-phenyltheophylline or theophylline into CSFreduces the hypoxic and hypercapnic dilatation or rat pial arterioles or CBF, respectively (3, 15) . Adenosineis also a potent neuromodulator of synaptic transmission that may funcion as an endogenous anticonvulsant ( 1 6) . Adenosine triphosphate (ATP) is co-released with neurotransmitters from synaptic terminals (17, 18) and is hydrolyzed to adenosine in the synaptic cleft (19) . Therefore, adenosine may be released in abundant amountswith the release of neurotransmitters in brain ischemia (20, 21) . High levels of adenosine in the CSFof patients with status epilepticus have been reported (22) . In the brains of patients with meningitis, ATPdepletion takes place, and subsequently the degradation products including adenosine increase (23) .
In pathological conditions such as brain ischemia, hypoxia, and injury, the CSFadenosine levels are presumed to increase. There are a fewreports whichmeasuredCSFadenosine levels in patients with cerebral thrombosis. In the present study, to determine whether CSFadenosine levels are increased in neurological disorders and whether the CSF adenosine level contributes to the neurological disorders, weexaminedthe adenosine levels in CSF samples from patients with varying neurological disorders. Wealso measured the inosine, xanthine and hypoxanthine levels in the CSF, quantified together with adenosine levels by the same high-performance liquid chromatography (HPLC) to determine whether these levels are increased like those of adenosine.
Neopterin, a pyrazino-pyrimidine compoundbiosynthesized from guanosine triphosphate in macrophages, is an in vitro indicator of immunesystem activation (24) (25) (26) . Increased neopterin levels in the CSFindicate a mononuclear cellular infiltration of the central nervous system (CNS). Wedetermined the CSF levels of neopterin in neurological disorders including human T-lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) (27) , amyotrophic lateral sclerosis (ALS) and cerebral infarction.
Increased CSF neopterin levels in patients with HAM/TSPhave been reported (28) . HAM/TSP is a chronic progressive HTLV-I infectious myelopathy that presents clinically as paraplegia with neurogenic bladder and mild sensory disturbances, and is characterized by an activated T-lymphocyte infiltration of the spinal cord (29) . Herein, we examined the sensitivity of CSF neopterin levels as a marker of CNSinflammation by comparing the neopterin levels with the cell numbers, protein levels, and glucose levels in the CSF of patients with HAM/TSP. We also investigated whether the adenosine and neopterin levels in the same CSFsamples to contribute the diagnosis of HAM/ TSP.
Subjects and Methods
Our subjects were inpatients at the Kagoshima University
Hospital or Kikuno Hospital in Kagoshima Prefecture, Japan. Control CSFsamples were obtained from patients with a bone fracture of the leg and without neurological disorders [n=39, 55±18 years (mean±SD), 15-87 years (12 men and 27 women)] when they received spinal anesthesia for surgery. All patients and control individuals gave their informed consent to all procedures. The patient CSFsamples which were collected to check the anti-HTLV-I antibody titer for the diagnosis of HAM/TSP or HTLV-I-related diseases were used for this study. 69 years) who were diagnosed by neurological status and the findings of electromyography, and patients with polyneuropathy (n=9, 54±15 years, 16-70 years) consisting of hereditary motosensory neuropathy and toxic neuropathy. To determine the adenosine level, 20 (il of concentrated perchloric acid was addedto one ml of CSFto inactivate adenosine deaminase soon after the CSF was drawn. The first 2 to 3 ml ofCSF was discarded and the second 2 to 3 ml was used to avoid the effect of artificial bleeding. The cell count, protein and glucose assays were performed in the clinical laboratory of Kagoshima University Hospital. The CSF samples for adenosine dtermination were neutralized with 100 jllI of 2 MKHCO3and centrifuged at 3,000 rpm for 10 minutes. The supernatant was kept at -20°C until the assay. Within 2 weeks, the samples were thawed and subjected to HPLC (JASCO880-PU with 820-FP and 875-UV, Japan Spectroscopic Co., Tokyo) in an apparatus equipped with an isocratic cation-exchange column, SP-2SW 4.6x250 mm(Tosoh Co., Tokyo) using an elution buffer of 185 mMNa acetate, pH4.2, according to the method of Morimoto et al (30) . The inosine and hypoxanthine-xanthine levels in the CSF were determined together with the adenosine levels by HPLC(hypoxanthine and xanthine could not be separated in this HPLCsystem). The neopterin level in the CSF was determined by the method of Fukushima and Nixon (31) . For this assay system, CSFsamples were kept at -20°C without the addition of the concentrated perchloric acid, and determinations were carried out within 2 weeks of the sample collection. Chemicals were obtained from WakoPure Chemical Industry (Osaka). Statistical analyses were performed with a Macintosh computer (Apple) using Statview version 4.5 software (Abacus Concepts, Inc., Berkeley, CA). Student's t-test was used when a significant F ratio was not found in the analysis of variance (ANOVA). Otherwise, Mann-Whitney U-test was performed for each variable. The significance level was set at p<0.05.
Results
One, four, or seven nmol of adenosine was added to each lml of CSF containing 0.49 nmol/ml of adenosine, and the mean recovery rates were 93.5+10.2% 100.1+2.0%, and 95.2±4.5% in 5 determinations, respectively. The coefficients of variability were 10.9%, 3.4%, and 4.1% in the five consecutive determinations of CSF containing 1.2 nmol/ml, 3.6 nmol/ ml, 6.8 nmol/ml each of adenosine, respectively. The adenosine levels were 0.55±0.22 nmol/ml in the control subjects (there was no significant difference between the levels of the men and those of the women), 1.02±1.25 nmol/ml in the patients with HAM/TSP,2.71±1.09 nmol/ml in the patients with acute-stage cerebral infarction, 0.7 1±0.22 nmol/ml in the patients with chronic-stage cerebral infarction, 1.58+0.58 nmol/ml in the patients with acute meningitis, 0.95+0.5 1 nmol/ ml in the patients with ALS, and 0.47±0.20 nmol/ml in the patients with polyneuropathy (Fig. 1 ).
There were significant differences in adenosine levels between the control subjects and the patients with acute-stage cerebral infarction (p<0.0001), those with acute meningitis (p<0.0001), and those with ALS (p<0.05) as shown by the Mann-Whitney U-test; however, no significant difference was recognized between the control subjects and the patients with HAM/TSP by this test, or between the controls and the patients with chronic-stage cerebral infarction or polyneuropa- thy as shown by Student's t-test. The inosine and hypoxanthine-xanthine levels in CSF were 7.88+2.62 nmol/ml and 5.93±3.57 nmol/ml in the control subjects, 6.74±2.86 nmol/ml and 6.98±4.50 nmol/ml in the HAM/TSP patients, 9.15+4.90 nmol/ml and 6.88±4. 13 nmol/ml in the acute-stage cerebral infarction patients, 8.51±3.55 nmol/ml and 7.35±4.91 nmol/ ml in the chronic-stage cerebral infarction patients, 7.87±2.06 nmol/ml and 12.81+1 1.68 nmol/ml in the acute meningitis patients, 9.89±4.08 nmol/ml and 8.03±3.85 nmol/ml in the ALS patients, and 6.4612.66 nmol/ml and 4.0811.41 nmol/ml in the patients with polyneuropathy. The levels of inosine and hypoxanthine-xanthine were not increased in the patitents with HAM/TSP, any stage of cerebral infarction, acute meningitis, ALS, or polyneuropathy compared to the control subjects. The neopterin levels in the CSF were 16.015.3 pmol/ml in the normal control subjects, which is in agreement with a previous report (28) , 127.0+107.5 pmol/ml in the patients with HAM/TSP, 22.013.4 pmol/ml in the acute-stage cerebral infarction patients, 1 6.617.3 pmol/ml in the patients with chronicstage cerebral infarction, 342.41254.7 pmol/ml in the acute meningitis patients, and 23.7+10.2 pmol/ml in the patients with ALS, and 1 8.213.0 pmol/ml in the polyneuropathy patients (Fig.  2 ). Significant differences were found between the control subjects and the patients with HAM/TSP (p<0.0001), those with acute meningitis (p<0.0001), and those with ALS (p<0.05) by the Mann-Whitney U-test, and those with acute-stage cerebral infarction (p<0.005) by Student' s t-test; however, no significant differences were found between the control subjects and the patients with chronic-stage cerebral infarction or polyneuropathy by Student' s t-test.
The regression analyses of the relation of adenosine or neopterin levels with the CSFcell numbers, protein levels, or glucose levels in the HAM/TSPpatients were performed and the coefficients of correlation (r) of the adenosine levels to the CSFcell numbers, protein levels and glucose levels in the CSF samples were 0.024 (p=0.88, ANOVA), 0.099 (p=0.054), and 0.443 (p=0.053), respectively. Those of the neopterin levels to the CSF cell numbers, protein levels and glucose levels were 0.314 (p=0.046, Fig. 3 (p=0.003, Fig. 5 ), respectively. There were thus significant correlations between the neopterin levels and the cell numbers and glucose levels in the HAM/TSPpatients. The CSF neopterin levels were extremely increased and were more sensitive to cerebrospinal cellular infiltration compared with the cell numbers, the protein levels, or the glucose levels. Figure 6 shows the CSF neopterin levels plotted on the ordinate and the CSFadenosine levels on the abscissa for several types of patients and the controls. The levels of adenosine were high in the patients with acute-stage cerebral infarction. In the patients with HAM/TSP, the neopterin levels were high. In the patients with acute meningitis, the levels of both neopterin and adenosine were increased compared with the controls. The adenosine levels were not significantly correlated with those of neopterin in the patients with HAM/TSP(coefficient of correlation, 0. 140, p>0. 1 , ANOVA).These results suggest that the neopterin levels of the present patients were independent of those of adenosine. Therefore, further analysis was carried out and among the eight patients with HAM/TSPwho had increased adenosine levels. In the patients with HAM/TSP, the relationship between the duration of illness and the neopterin level was as follows: let the neopterin levels denote Y and years passed X; the regression equation isY=-2.3X+167.9 and r=0. 137 (p>0. 1, n=60; in this analysis, the sample numberof the patients with HAM/ TSP was increased). The results indicated that the levels of neopterin in HAM/TSPpatients are diverse and the monocytic infiltration remains for a long time after the onset.
Discussion
Adenosine levels in the CSF were intensely increased in the patients with acute-stage cerebral infarction and were significantly increased in the patients with acute meningitis or ALS, which might reflect the rapid ATPdegradation induced by the destruction of the cortex or spinal cord. Wedetermined the CSF adenosine levels in patients with acute-stage cerebral infarction with a serious disturbance of consciousness, because we speculated that the consciousness loss was correlated with the volumeof the infarct and surrounding edematousarea and with the decrease of cerebral blood flow. The adenosine level appears to be a marker of brain hypoxia or ischemia as well as cerebrospinal cellular injury. In the present patients with acutestage cerebral infarction, the CSF levels of inosine, hypoxanthine, and xanthine, which were the degradation products of adenosine, were not increased; only the adenosine levels were increased. These results suggest that adenosine, inosine, hypoxanthine, and xanthine are differently metabolized. Wedid not determine the xanthine and hypoxanthine levels separately, because the xanthine and hypoxanthine levels were not increased significantly in the patients with acute-stage cerebral infarction compared with the normal controls in the preliminary experiments, and wedecided to elute adenosine rapidly to save time, determining the adenosine levels by HPLC. Even in the patients with acute cerebral infarction, the adenosine levels were not as high as expected prior to the determination. CSF adenosine levels were not found to be high in patients with febrile convulsion (33) , and the levels were only slightly high even in patients with status epilepticus, compared to normal control subjects (22) . This is due to the short half-life of adenosine (5, 30) , because adenosine is taken up soon in synaptic terminals and glial cells. The adenosine levels of the patients with acute cerebral infarction in the present study are consistent with a previous report of rat hypoxia (34) . The neopterin levels in the CSFof the present patients with HAM/TSPas well as those with acute meningitis were significantly increased (35) (36) (37) (38) . The neopterin levels were slightly increased in the acute-stage cerebral infarction and ALSpatients. These results may be indicative of mononuclear cellular infiltration and immunological involvement in these disorders (39, 40) .
The CSFneopterin levels were significantly correlated to the CSFcell numbers and glucose levels but not the protein levels in the present HAM/TSPpatient group. It is well-known that the decrease of the glucose levels in CSFare related to the severity of the CNSinflammation such as bacterial, tuberculous, fungal meningitis, and leptomeningeal carcinomatosis, but not viral meningitis. Increased use of glucose in brain induced by the anaerobic metabolism and the disturbance of glucose transport across the blood-brain barrier contributes to the development of the decreased glucose levels in bacterial, tuberculous, and fungal meningitis (41) . In leptomeningeal carcinomatosis, the glucose transport in choroid plexus is disturbed (42). Although the CSF glucose level is accepted not to decrease in viral meningitis, the glucose levels in the patients with HAM/TSP,chronic viral myelitis were reversely correlated to the neopterin levels, a marker of CNSinflammation. The results suggest that the glucose levels are probably decreased in CNSviral infectious disease. In the present study, a lumbar puncture of the inpatients with HAM/TSPwas done in the morning. Therefore, under the slight influence of the blood glucose levels, the decrease of CSF glucose levels are correlated with the neopterin levels (Fig. 5) . The coefficients of correlation (r) between the levels of cell numbers or glucose levels and neopterin levels were small. The increase in the neopterin levels was prominent comparedwith those of the cell numbers and the protein levels in the CSFsamples. These results showthat the CSFneopterin level is an intensely sensitive marker of CNSinflammation. The CSF adenosine levels were not correlated with the cell Internal Medicine Vol. 38, No. 2 (February 1999) count, the protein level, or the glucose levels in the CSF samples. Increased adenosine levels were found in the patients with HAM/TSP whohad complications, while the other patients without increased adenosine levels had no complications. It is unknown whether the CSFadenosine levels are increased in the complications of Parkinson's disease, arterio-venous malformation, OYL,and Sjogren's syndrome, among others. A possibility that the adenosine levels were increased in the CSF samples of the non-complication patients with HAM/TSP remains; however, in light of the not very high adenosine levels in the patients with acute meningitis in whomsevere inflammation was breaking out, such complications might cause the increased adenosine levels observed here in HAM/TSPpatients. In addition, the persistent increase of neopterin levels verified that HAM/TSP was a chronic type of progressive myelitis. The mononuclearcellular infiltration remained for a long time in patients with HAM/TSP, although it has been reported that the inflammation in the spinal cord is ameliorated naturally over time based on a study of CD4and CDSlymphocytic infiltration, in a histochemical study (29) .
